The above findings were confirmed in primary Lin-CD34+ cells from MPN patients (Table 1), as with the cell lines, these were co-cultured with HS-5 BM stromal cells in the presence of the pharmacological agents. The gene discussed is CD34; the disease is myeloproliferative neoplasm.